Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Pharmaceutical Development Services

We offer pharmaceutical development services for oral solids, liquids, creams, ointment and sterile injectable from our facilities in US, UK and India. As a leader in integrated solutions, we seamlessly engage our global sites to conduct development work in parallel; accelerating time to market and reduce costs for our customers.

Pharmaceutical Development Capabilities

  • Phase I to III clinical development (NCEs)
    • Oral Solids
    • Sterile Injectables
    • Liquid filled Capsules
    • Creams and Ointments
    • Powder-in-bottle to Drug-in-Capsules
  • Formulation Development in various dosage Forms
    • Oral Solids
      • Conventional oral solid forms
      • Oral disintegrating tablets
      • Sublingual tablets
      • Press coated tablets (Sub coated tablets)
      • Bi-layered, Delayed release, Modified release
      • Granules for reconstitution
    • Sterile Formulations
      • Sterile Liquids – Injectable & Ophthalmic
      • Lyophilized products
      • In-situ salt formations
      • Non-aqueous formulations for liquid
      • Nanoparticles and Liposomes
    • Creams and Ointments
  • Paediatric formulations
  • Hormonal formulations (Oral contraceptive pills)
  • Controlled drug substances
  • Oncology drug products (Sterile and Solid Dosages)

Key Features of Pharmaceutical Development

  • Supports development to clinical manufacturing (50 g to 35 kg)
  • Blinding by over-encapsulation
  • Capability to handle low RH compounds handling (<30%)
  • High-potency compounds (OEL: 1 µg/m3)
  • Design of experiments using Statistica software
  • Multi-particulates (GPCG 2 and 30)
  • Explosion-proof area for handling non-aqueous Solvents
  • Manufacturing suites for liquids, creams and ointment production
  • Specialized IPQC tools such as Geopyc, Shulze Ring-shear tester for powder / compacts evaluation, sifting & fluidization type Segregation Testers